1st Quarter - Report

MEHLMAN CONSULTING, INC. for VIZIENT INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

340b drug pricing program. Issues related to pharmacy benefit manager reform. Health care workforce. Health care supply chain. Health care drug shortages. Pandemic All-Hazard Preparedness Act Reauthorization. The Stop Drug Shortages Act (No Bill Number) discussion draft. H.R. 3008 - The Drug Shortage Prevention Act. H.R. 3810 - The Drug Origin Transparency Act.

LobbyistCovered position, as disclosed
LAUREN ARONSON —
ALYENE MLINAR —
DEAN ROSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3810 (118th), H.R. 3008 (118th)

Medicare/Medicaid MMM

PL 118-42/H.R. 4366 - Consolidated Appropriations Act of 2024. PL 118-47/H.R. 2882 - Consolidated Appropriations Act of 2024.

LobbyistCovered position, as disclosed
LAUREN ARONSON —
ALYENE MLINAR —
DEAN ROSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4366 (118th), H.R. 2882 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.